TickerFactsScreenerDevelopers

KYNTRA BIO, INC. (KYNB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$7.95M2014: -$50.10M2015: -$77.62M2016: -$50.04M2017: -$117.28M2018: -$86.69M2019: -$89.31M2020: -$191.88M2021: -$288.53M2022: -$301.02M2023: -$322.72M2024: -$150.42M2025: -$45.90M-$45.90M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$45.90M+69.5%
2024-$150.42M+53.4%
2023-$322.72M-7.2%
2022-$301.02M-4.3%
2021-$288.53M-50.4%
2020-$191.88M-114.8%
2019-$89.31M-3.0%
2018-$86.69M+26.1%
2017-$117.28M-134.4%
2016-$50.04M+35.5%
2015-$77.62M-54.9%
2014-$50.10M-530.3%
2013-$7.95M—